U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07004725) titled 'Therapy of Niacin for Rheumatoid Arthritis' on Dec. 15, 2024.
Brief Summary: This study is a study to evaluate the safety and efficacy of administering niacin sustained-release capsules to rheumatoid arthritis with hyperlipidemia patients. Sixty patients were randomly assigned to niacin or placebo for 12 weeks, followed by niacin for 12 weeks. Changes in disease activity score, immune cell subtypes, markers of intestinal damage, intestinal flora, and other laboratory indicators will be monitored.
Study Start Date: May 28
Study Type: INTERVENTIONAL
Condition:
Rheumatoid Arthritis (RA)
Intervention:
DRUG: niacin sustained release...